Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02497417 · ClinicalTrials.gov registry record
A Multi-Site Clinical Evaluation of the ARIES Clostridium Difficile Assay in Symptomatic Patients
A clinical trial, sponsored by Luminex Corporation.
- Completed
- Registry status
- 1,021
- Enrollment target
NCT02497417 is a clinical trial that has completed, run by Luminex Corporation. The registered enrollment target is 1,021 participants.
The verdict
NCT02497417 has completed, sponsored by Luminex Corporation.
- COMPLETED
- Registry status
- 1,021 participants
- Enrollment target
Study Summary
The ARIES C. difficile Assay is a real-time PCR based qualitative in vitro diagnostic test for the direct detection of C. difficile nucleic acid in stool specimens.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,021 participants |
| Start Date | 2016-10 |
| Est. Completion | 2017-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02497417
The ClinicalTrials.gov registry entry for NCT02497417 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,021 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Luminex Corporation, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02497417 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02497417 about?
NCT02497417 is a clinical study titled "A Multi-Site Clinical Evaluation of the ARIES Clostridium Difficile Assay in Symptomatic Patients". The ARIES C. difficile Assay is a real-time PCR based qualitative in vitro diagnostic test for the direct detection of C. difficile nucleic acid in stool specimens.
What is the current status of trial NCT02497417?
This trial is currently completed. The enrollment target is 1,021 participants. The study started on 2016-10. Estimated completion is 2017-02.
Who is sponsoring clinical trial NCT02497417?
This trial is sponsored by Luminex Corporation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.